285 related articles for article (PubMed ID: 24861879)
1. MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras.
Shi Z; Chen Q; Li C; Wang L; Qian X; Jiang C; Liu X; Wang X; Li H; Kang C; Jiang T; Liu LZ; You Y; Liu N; Jiang BH
Neuro Oncol; 2014 Oct; 16(10):1341-53. PubMed ID: 24861879
[TBL] [Abstract][Full Text] [Related]
2. MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma.
Wang L; Shi ZM; Jiang CF; Liu X; Chen QD; Qian X; Li DM; Ge X; Wang XF; Liu LZ; You YP; Liu N; Jiang BH
Oncotarget; 2014 Jul; 5(14):5416-27. PubMed ID: 24980823
[TBL] [Abstract][Full Text] [Related]
3. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
[TBL] [Abstract][Full Text] [Related]
4. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-1301 inhibits proliferation of human glioma cells by directly targeting N-Ras.
Zhi T; Jiang K; Zhang C; Xu X; Wu W; Nie E; Yu T; Zhou X; Bao Z; Jin X; Zhang J; Wang Y; Liu N
Am J Cancer Res; 2017; 7(4):982-998. PubMed ID: 28469970
[TBL] [Abstract][Full Text] [Related]
6. MiR-433-3p suppresses cell growth and enhances chemosensitivity by targeting CREB in human glioma.
Sun S; Wang X; Xu X; Di H; Du J; Xu B; Wang Q; Wang J
Oncotarget; 2017 Jan; 8(3):5057-5068. PubMed ID: 27926502
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma.
Zhang J; Zhang J; Qiu W; Zhang J; Li Y; Kong E; Lu A; Xu J; Lu X
J Neurooncol; 2018 Sep; 139(3):547-562. PubMed ID: 29774498
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-145 suppresses uveal melanoma angiogenesis and growth by targeting neuroblastoma RAS viral oncogene homolog and vascular endothelial growth factor.
Yang JY; Li Y; Wang Q; Zhou WJ; Yan YN; Wei WB
Chin Med J (Engl); 2020 Aug; 133(16):1922-1929. PubMed ID: 32826455
[TBL] [Abstract][Full Text] [Related]
9. MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2.
Zhang X; Yu J; Zhao C; Ren H; Yuan Z; Zhang B; Zhuang J; Wang J; Feng B
Biomed Pharmacother; 2019 Jan; 109():2192-2202. PubMed ID: 30551476
[TBL] [Abstract][Full Text] [Related]
10. MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT.
Nie E; Jin X; Wu W; Yu T; Zhou X; Shi Z; Zhang J; Liu N; You Y
J Neurooncol; 2017 May; 133(1):59-68. PubMed ID: 28425046
[TBL] [Abstract][Full Text] [Related]
11. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
12. miR-23b-5p promotes the chemosensitivity of temozolomide via negatively regulating TLR4 in glioma.
Gao K; Wang T; Qiao Y; Cui B
Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(8):979-987. PubMed ID: 34110366
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of circular RNA CEP128 suppresses proliferation and improves cytotoxic efficacy of temozolomide in glioma cells by regulating miR-145-5p.
Hua L; Huang L; Zhang X; Feng H; Shen B
Neuroreport; 2019 Dec; 30(18):1231-1238. PubMed ID: 31599823
[TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin.
Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS
Cancer Biol Ther; 2014 Apr; 15(4):398-408. PubMed ID: 24424202
[TBL] [Abstract][Full Text] [Related]
15. Sevoflurane blocks glioma malignant development by upregulating circRELN through circRELN-mediated miR-1290/RORA axis.
Kang X; Li H; Zhang Z
BMC Anesthesiol; 2021 Sep; 21(1):213. PubMed ID: 34479497
[TBL] [Abstract][Full Text] [Related]
16. Sevoflurane impedes the progression of glioma through modulating the circular RNA has_circ_0012129/miR-761/TGIF2 axis.
Xu W; Xue R; Xia R; Liu WW; Zheng JW; Tang L; Kang LY; Wang W; Wei WT
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5534-5548. PubMed ID: 32495888
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-936 induces cell cycle arrest and inhibits glioma cell proliferation by targeting CKS1.
Wang D; Zhi T; Xu X; Bao Z; Fan L; Li Z; Ji J; Liu N
Am J Cancer Res; 2017; 7(11):2131-2143. PubMed ID: 29218238
[TBL] [Abstract][Full Text] [Related]
18. NF-κB-mediated miR-650 plays oncogenic roles and activates AKT/ERK/NF-κB pathways by targeting RERG in glioma cells.
Jin S; Li X; Dai Y; Li C; Wang D
Cell Oncol (Dordr); 2020 Dec; 43(6):1035-1048. PubMed ID: 32986146
[TBL] [Abstract][Full Text] [Related]
19. miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.
Wang J; Sai K; Chen FR; Chen ZP
Cancer Chemother Pharmacol; 2013 Jul; 72(1):147-58. PubMed ID: 23645289
[TBL] [Abstract][Full Text] [Related]
20. FTO Inhibition Enhances the Antitumor Effect of Temozolomide by Targeting MYC-miR-155/23a Cluster-MXI1 Feedback Circuit in Glioma.
Xiao L; Li X; Mu Z; Zhou J; Zhou P; Xie C; Jiang S
Cancer Res; 2020 Sep; 80(18):3945-3958. PubMed ID: 32680921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
